ClinicalTrials.Veeva

Menu

Retinal Imaging Using NOTAL-OCT

Notal Vision logo

Notal Vision

Status

Completed

Conditions

Age-Related Macular Degeneration
Diabetic Retinopathy

Treatments

Device: Notal OCT

Study type

Observational

Funder types

Industry

Identifiers

NCT03374020
BNZ-0077-017

Details and patient eligibility

About

Comparison between retinal measurements, done by the Notal-OCT imaging and a commercial OCT (Optical Coherence Tomography)

Enrollment

33 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Ability and agreement to give informed consent (IC)
  2. Diagnosis of AMD or DR in SE by OCT
  3. Ability to undergo OCT scans
  4. VA of 20/160 or better in SE

Exclusion criteria

  1. AMD and DR in the same SE
  2. Evidence of macular disease other than AMD or DME in SE

Trial design

33 participants in 4 patient groups

Intermediate AMD
Treatment:
Device: Notal OCT
Advanced AMD
Treatment:
Device: Notal OCT
DR without macular edema
Treatment:
Device: Notal OCT
DR with macular edema
Treatment:
Device: Notal OCT

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems